Table 1.
Patient and treatment characteristics at baseline according to treatment received
SAP (n =227) |
TAP (n =237) |
|
---|---|---|
Age (years), mean(s.d.) | 48.8 (14.0) | 48.9 (14.4) |
Sex ratio (M : F) | 72 : 155 | 81 : 156 |
BMI (kg/m2), mean(s.d.) | 27.4 (5.0) | 26.9 (4.8) |
SFJ reflux present | 195 (85.9) | 219 (92.4) |
Refluxing saphenous trunk | ||
ȃGSV | 145 (63.9) | 147 (62.0) |
ȃAASV | 80 (35.2) | 87 (36.7) |
ȃMissing | 2 (0.9) | 3 (1.3) |
VCSS at baseline, mean(s.d.) | 6.0 (2.2) | 5.9 (2.3) |
C(EAP) class | ||
ȃC2 | 66 (29.1) | 66 (27.8) |
ȃC3 | 94 (41.4) | 108 (45.6) |
ȃC4–6 | 57 (25.1) | 54 (22.8) |
ȃMissing | 10 (4.4) | 9 (3.8) |
Total phlebectomy length (cm) | ||
ȃ< 15 | 10 (4.4) | 27 (11.4) |
ȃ15–30 | 81 (35.7) | 79 (33.3) |
ȃ> 30 | 131 (57.7) | 110 (46.4) |
ȃMissing | 5 (2.2) | 21 (8.9) |
Length of treated trunk (cm), mean(s.d.) | – | 20.9 (10.7) |
Energy used (J/cm), mean(s.d.) | – | 60.6 (14.9) |
Values are n (%), unless otherwise indicated. SAP, isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation; TAP, thermal ablation with concomitant phlebectomy; SFJ, saphenofemoral junction; GSV, great saphenous vein; AASV, anterior accessory saphenous vein; VCSS, Venous Clinical Severity Score; CEAP, Clinical Etiologic Anatomic Pathophysiologic.